Search
Now showing items 1-4 of 4
Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas Implications for AIDS vaccine development using Sendai virus vectors
(2011-06)
A Sendai Virus (Sev) vector is being developed for an HIV immunogen. SeV is not known to cause disease in humans. Because it is genetically and antigenically related to human parainfluenza virus type 1 (hPIV-1), it is ...
Building capacity for cervical cancer screening in outpatient HIV clinics in the Nyanza province of western Kenya
(2011)
Objective
To evaluate outcomes of cervical cancer screening within HIV care and treatment clinics in Kenya.
Methods
Beginning in October 2007, visual inspection with acetic acid (VIA), colposcopy, and loop electrosurgical ...
A Randomized Controlled Trial Comparing the Effects of Counseling and Alarm Device on HAART Adherence and Virologic Outcomes
(2011)
Background
Behavioral interventions that promote adherence to antiretroviral medications may decrease HIV treatment failure. Antiretroviral treatment programs in sub-Saharan Africa confront increasing financial constraints ...
Barriers to Antiretroviral Initiation in HIV-1-Discordant Couples
(2011)
BACKGROUND
In Kenya and much of sub-Saharan Africa, nearly half of all couples affected by HIV are discordant. Antiretroviral therapy (ART) slows disease progression in HIV-1-infected individuals, and reduces transmission ...